Close Menu

Somalogic

NEW YORK (GenomeWeb) – Somalogic said today that Novartis has extended its multi-year research agreement covering the use of Somalogic's aptamer-based proteomics platform for drug development work.

NEW YORK (GenomeWeb) – Children's Hospital Colorado and SomaLogic today announced a collaboration aimed at the discovery of protein biomarkers for diagnosing and managing childhood diseases.

NEW YORK (GenomeWeb) – SomaLogic and NEC today announced an exclusive deal granting NEC exclusive marketing rights to the Somascan assay in Japan.

SomaLogic announced that the Massachusetts General Hospital will this fall begin offering access to the company's Somascan assay.
Based on SomaLogic's somamer affinity reagents, the Somascan platform allows for simultaneous quantification of 1,129 proteins.

NEW YORK (GenomeWeb) – Somalogic said this week that it has joined the Medical Research Council's UK Dementias Research Platform.

Protein Metrics has launched top-down proteomic analysis as part of the 2.0 release of its Byonic proteomics search engine.

NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has mad an adjustment to its second quarter 2014 GAAP net income.

NEW YORK (GenomeWeb News) – Somalogic said this week that it has received additional funding from the Bill & Melinda Gates Foundation for the development and validation of tuberculosis biomarker assays based on its Somamer technology.

Somalogic said this week that it has named Dan Muehl as chief financial officer.

While its diagnostic ambitions continue to progress slowly, proteomics firm Somalogic appears to be carving out a substantial market for its SOMAscan protein biomarker discovery platform, generating $10.5 million in revenues from the product in 2013.

Pages

Retraction Watch reports that a paper was pulled because it refers to a gene that doesn't exist in mice.

Researchers were able to generate fertilized northern white rhinoceros eggs, according to Mashable.

Former Orig3n employees raise concerns about its testing at Bloomberg Businessweek.

In PLOS this week: microRNA expression changes in hepatocellular carcinoma, real-time PCR-based approach for diagnosing schistosomiasis, and more.